How to prevent recurrence of overt hepatic encephalopathy?

Question

Hello Doctor,

My father is 61 years old and has been living with liver cirrhosis for approximately three years. Last week, he developed significant confusion; he was unable to recognize family members and was speaking incoherently. A few months ago, the hospital started him on a new medication, though we are uncertain whether he has been taking it consistently.

Yesterday, his ammonia level was reported at 189 µmol/L. He has also been experiencing a reversal of his sleep pattern, sleeping most of the day and remaining awake at night, which has been very challenging for our family.

The medical team mentioned that he is experiencing overt hepatic encephalopathy, but we would appreciate further clarification regarding what may trigger these episodes. We are also unsure whether his current medication regimen should be adjusted either in dosage or by adding another therapy to help prevent recurrence.

He is currently taking lactulose; however, he frequently skips doses due to bloating and discomfort. Could you please advise on the best next steps to help stabilize his condition and reduce the risk of future episodes?

Thank you for your guidance.

Answer 1

Hi,

Welcome to icliniq.com.

I deeply regret that your family needs to manage this difficult situation. The symptoms you described, particularly sleeping during the day and staying awake at night, are classic features of overt hepatic encephalopathy. His confusion and behavioral changes became more severe because his ammonia level reached 189 µmol/L, which represents a serious health hazard.

The liver stops functioning when it cannot remove toxins from the blood, which includes ammonia. The accumulation of these toxins leads to brain function impairment,which causes the symptoms you are observing.

These episodes occur because particular reversible factors trigger them instead of showing that liver disease has progressed. Common triggers include missed doses of lactulose, constipation, dehydration, infections, gastrointestinal bleeding, kidney dysfunction, or electrolyte imbalances. The sudden deterioration occurs because a trigger affects existing cirrhosis.

Daily lactulose use must happen without exception. The therapeutic goal is to achieve two to three soft bowel movements per day because this practice helps decrease ammonia absorption. The group of patients who skip their doses will experience recurrence. The dosing schedule requires either smaller amounts to be given more frequently or a different method of administration because bloating limits adherence. His physician needs to evaluate this situation before they make any decisions about stopping the medication.

Rifaximin functions as a protective additive to lactulose for patients who experience multiple episodes.

The patient requires immediate medical assessment when his confusion reaches its most extreme state. The gastroenterologist will need to observe the patient closely after stabilization happens because their ammonia levels will improve to decrease the chances of future episodes occurring.

I hope this addresses your concern.

Please provide comments and let me know if you have any more questions.

I would be pleased to assist you further.

Thank you.